Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzoate evogliptin tablets in type 2 diabetes mellitus
CTR20180329Phase 2Completed
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DA5221-B2 in type 2 diabetes mellitus (T2DM), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Mar 2018; status: completed.
02
Drugs
DA5221-B2
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20180329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180329.